Brief report Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients

Brief report : Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 231(2021) vom: 01. Okt., Seite 108828
1. Verfasser: Mathi, Kavita (VerfasserIn)
Weitere Verfasser: Rosenberg-Hasson, Yael, Maecker, Holden, Carlo, Dennis J, Moss, Ronald B
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Antigen presenting cells COVID-19 Cytokines Inflammation T cells Tempol Antigens, Viral Antioxidants mehr... Cyclic N-Oxides Spin Labels tempol U78ZX2F65X
Online verfügbar Volltext